Helicos Cuts Headcount in Half in Bid to Cut Costs; Seeks to Refocus on Dx Applications | GenomeWeb

This article, originally published May 17, has been updated with information from a recent filing with the SEC regarding Helicos' first-quarter earnings results.

By Julia Karow

Helicos BioSciences has laid off half of its staff in a bid to cut costs, and plans to reposition its technology for diagnostic applications, the firm said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.